lybrido; sexual interest/arousal disorder

https://www.pharmaceutical-technology.com/news/female-sexual-interest-drug-reaches-tipping-point-with-phase-iii-plans/ Freya Pharma has received EMA guidance to take its pill Lybrido into Phase III trials to treat female sexual interest disorder. After more than a decade in development, Freya...